Selective activation of NF-κB and E2F by low concentration of arsenite in U937 human monocytic leukemia cells

Journal of Biochemical and Molecular Toxicology

Volumn 22, Issue 2, 2008, Pages 136-146

  Yamamoto, Megumi ^a,b   Hirano, Seishiro ^a   Vogel, Christoph F A ^c   Cui, Xing ^a   Matsumura, Fumio ^c  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b NATIONAL INSTITUTE FOR MINAMATA DISEASE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arsenite; E2F; Inflammation; Macrophage; Monocyte; NF B; RelB

Indexed keywords

ARSENIC TRIOXIDE; B CELL ACTIVATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LUCIFERASE; MESSENGER RNA; PROTEIN P50; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL ADHESION; CELL STRAIN U937; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MICROARRAY ANALYSIS; MONOCYTE; PROTEIN FUNCTION;

ARSENITES; BASE SEQUENCE; CELL SURVIVAL; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; E2F TRANSCRIPTION FACTORS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; NF-KAPPA B; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; U937 CELLS;

EID: 43249131265     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20222     Document Type: Article

References (31)

1. Bode AM, Dong ZG. The paradox of arsenic: Molecular mechanisms of cell transformation and chemotherapeutic effects. Crit Rev Oncol Hematol 2002;42(1):5-24.
2. Chen F, Shi XL. Intracellular signal transduction of cells in response to carcinogenic metals. Crit Rev Oncol Hematol 2002;42(1):105-121.
3. Fernandez C, Ramos AM, Sancho P, Amran D, de Blas E, Aller P. 12-O-tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells - regulation by extracellular signal-regulated protein kinases and glutathione. J Biol Chem 2004;279(5):3877-3884.
4. McCabe MJ, Singh KP, Reddy SA, Chelladurai B, Pounds JG, Reiners JJ, States JC. Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phase. J Pharmacol Exp Ther 2000;295(2):724-733.
5. Wu MM, Chiou HY, Ho IC, Chen CJ, Lee TC. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ Health Perspect 2003;111(11):1429-1438.
6. Lu T, Liu J, LeCluyse EL, Zhou YS, Cheng ML, Waalkes MP. Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China. Toxicol Sci 2001;59(1):185-192.
7. Sakurai T, Ohta T, Tomita N, Kojima C, Hariya Y, Mizukami A, Fujiwara K. Evaluation of immunotoxic and immunodisruptive effects of inorganic arsenite on human monocytes/macrophages. Int Immunopharmacol 2006;6(2):304-315.
8. Karin M, Greten FR. NF-κB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005;5(10):749-759.
9. Vogel CF, Sciullo E, Wong P, Kuzmicky P, Kado N, Matsumura F. Induction of proinflammatory cytokines and C-reactive protein in human macrophage cell line U937 exposed to air pollution particulates. Environ Health Perspect 2005;113(11):1536-1541.
10. Hirano S, Kanno S. Syk and paxillin are differentially phosphorylated following adhesion to the plastic substrate in rat alveolar macrophages. Immunology 1999;97(3):414-419.
11. Kim J, Feldman RA. Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1. Mol Cell Biol 2002;22(6):1903-1918.
12. Vogel CF, Sciullo E, Li W, Wong P, Lazennec G, Matsumura F. RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol Endocrinol 2007;21(12):2941-2955.
13. Jiang X, Norman M, Roth L, Li XQ. ProteinDNA array-based identification of transcription factor activities regulated by interaction with the glucocorticoid receptor. J Biol Chem 2004;279(37):38480-38485.
14. Valledor AF, Borras FE, Cullell-Young M, Celada A. Transcription factors that regulate monocyte/macrophage differentiation. J Leukoc Biol 1998;63(4):405-417.
15. Skalnik DG. Transcriptional mechanisms regulating myeloid-specific genes. Gene 2002;284(1/2):1-21.
16. Ito CY, Kazantsev AG, Baldwin AS Jr. Three NF-κB sites in the I κB-alpha promoter are required for induction of gene expression by TNFα. Nucl Acids Res 1994;22(18):3787-3792.
17. Cogswell JP, Godlevski MM, Wisely GB, Clay WC, Leesnitzer LM, Ways JP, Gray JG. NF-κB regulates IL-1 beta transcription through a consensus NF-κB binding site and a nonconsensus CRE-like site. J Immunol 1994;153(2):712-723.
18. Zhang Y, Broser M, Rom W. Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF IL 6 and NF-κB. Proc Natl Acad Sci USA 1995;92(8):3632.
19. Roebuck KA. Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 1999;19(5):429-438.
20. Bossen C, Schneider P. BAFF, APRIL and their receptors: Structure, function and signaling. Semin Immunol 2006;18(5):263-275.
21. Dejardin E. The alternative NF-κB pathway from biochemistry to biology: Pitfalls and promises for future drug development. Biochem Pharmacol 2006;72(9):1161-1179.
22. Jaspers I, Samet JM, Reed W. Arsenite exposure of cultured airway epithelial cells activates κB-dependent interleukin-8 gene expression in the absence of nuclear factor-κB nuclear translocation. J Biol Chem 1999;274(43):31025-31033.
23. Carey JO, Posekany KJ, deVente JE, Pettit GR, Ways DK. Phorbol ester-stimulated phosphorylation of PU.1: Association with leukemic cell growth inhibition. Blood 1996;87(10):4316-4324.
24. Bell LA, Ryan KM. Life and death decisions by E2F-1. Cell Death Differ 2004;11(2):137-142.
25. Ginsberg D. E2F1 pathways to apoptosis. FEBS Lett 2002;529(1):122-125.
26. Trouba KJ, Wauson EM, Vorce RL. Sodium arsenite-induced dysregulation of proteins involved in proliferative signaling. Toxicol Appl Pharmacol 2000;164(2):161-170.
27. Qian Y, Castranova V, Shi X. New perspectives in arsenic-induced cell signal transduction. J Inorg Biochem 2003;96(2/3):271-278.
28. Amanullah A, Hoffman B, Liebermann DA. Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15(INK4B) and p16(INK4A). Blood 2000;96(2):475-482.
29. Tanaka H, Matsumura I, Ezoe S, Satoh Y, Sakamaki T, Albanese C, Machii T, Pestell RG, Kanakura Y. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-κB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 2002;9(5):1017-1029.
30. Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell 1999;4(5):771-781.
31. Chen M, Capps C, Willerson JT, Zoldhelyi P. E2F-1 regulates nuclear factor-κB activity and cell adhesion - potential antiinflammatory activity of the transcription factor E2F-1. Circulation 2002;106(21):2707-2713.